(Q42520917)

1 November 2017

title

Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice (English)

1 reference

1 November 2017

Wenrui Duan

1

1 reference

1 November 2017

Li Gao

2

1 reference

1 November 2017

David Jin

3

1 reference

1 November 2017

Gregory A Otterson

4

1 reference

1 November 2017

Miguel A Villalona-Calero

5

1 reference

1 November 2017

publication date

30 October 2007

1 reference

1 November 2017

1 reference

1 November 2017

volume

17

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

355-366

1 reference

Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

1 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11248-007-9154-3

Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11248-007-9154-3

p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11248-007-9154-3

RT-PCR heteroduplex analysis permits differentiation of transgene and host gene expression in a transgenic animal model

21 January 2018

1 reference

12 December 2020

Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice

1 reference

12 December 2020

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

12 December 2020

Gain of function mutations in p53.

1 reference

12 December 2020

Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice

1 reference

12 December 2020

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

1 reference

12 December 2020

The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity.

1 reference

12 December 2020

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

12 December 2020

p21(CIP1) Controls proliferating cell nuclear antigen level in adult cardiomyocytes

1 reference

12 December 2020

High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors

1 reference

12 December 2020

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

1 reference

12 December 2020

Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Radiation-induced cell cycle arrest compromised by p21 deficiency

1 reference

12 December 2020

Gain-of-function mutations in the tumor suppressor gene p53.

1 reference

12 December 2020

Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control

1 reference

12 December 2020

Epidemiology of lung cancer: looking to the future.

1 reference

12 December 2020

Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.

1 reference

12 December 2020

p21 is a universal inhibitor of cyclin kinases

1 reference

12 December 2020

Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines

1 reference

12 December 2020

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

1 reference

12 December 2020

Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53

1 reference

12 December 2020

Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.

1 reference

12 December 2020

p53: puzzle and paradigm

1 reference

12 December 2020

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

12 December 2020

Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants.

1 reference

12 December 2020

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

1 reference

12 December 2020

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

12 December 2020

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

12 December 2020

Novel DNA binding of p53 mutants and their role in transcriptional activation.

1 reference

12 December 2020

Oncogenic forms of p53 inhibit p53-regulated gene expression

1 reference

12 December 2020

Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins

1 reference

12 December 2020

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features

1 reference

12 December 2020

10.1007/S11248-007-9154-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1020586014

0 references

1 reference